In this episode of the cc: Life Science Podcast series, Chris Conner speaks with AlidaBio CEO and co-founder Dr. Gudrun Stengel about the emerging science of RNA modifications, chemical changes that fine‑tune gene expression. Dr. Stengel discusses how the “hidden code” shapes cell fate decisions and influences disease trajectories. She also explains how AlidaBio’s EpiPlexTM platform is pushing the field forward with robust, sequencing‑based detection of RNA modifications such as m6A, inosine and pseudouridine, bringing new clarity to cancer biology, stem cell research, and even crop engineering.
Listen: https://cclifescience.substack.com/p/rna-modifications